Antioxidant strategy to counteract the side effects of antipsychotic therapy: an in vivo study in rats

被引:4
作者
Besret, L [1 ]
Caldwell, MA [1 ]
Torres, EM [1 ]
Dunnett, SB [1 ]
机构
[1] Univ Cambridge, Ctr Brain Repair, Cambridge, England
关键词
tyrosine hydroxylase; haloperidol; substantia nigra; immunohistochemistry; antioxidant; (rat);
D O I
10.1016/S0014-2999(00)00747-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of long-term administration of the dopamine D-2 receptor antagonist haloperidol on Parkinsonian symptoms have been shown to persist after cessation of the drug treatment. In order to determine whether the level of tyrosine hydroxylase could be affected by subchronic administration of haloperidol, we examined tyrosine hydroxylase-positive immunoreactive cells in the substantia nigra after blockade of dopaminergic receptors with this antipsychotic. Three weeks of injections with haloperidol (1.5 mg/kg, i.p.) caused a significant decrease in tyrosine hydroxylase-positive cell counts at 24 h (27%), 5 days (21%) and 2 weeks (10%) after the last administration, an effect that was blocked by concurrent administration of the antioxidant, vitamin C. The level of tyrosine hydroxylase returned to baseline after 4 weeks withdrawal, no change being observed at later time-points. Nissl staining demonstrated that no damage to the cell bodies was observed, suggesting that the decrease in tyrosine hydroxylase-positive cells was not due to dopaminergic cell loss. These results demonstrate a depleting action of a short course of haloperidol on nigral tyrosine hydroxylase that outlasts the period of application by 2-4 weeks. Moreover, the current study has shown the effect of the antioxidant vitamin C in protecting haloperidol effects on tyrosine hydroxylase-immunostaining. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 21 条
[1]   EFFECT OF DOPAMINE AGONISTS AND ANTAGONISTS ON DOPA FORMATION IN THE SUBSTANTIA NIGRA [J].
ARGIOLAS, A ;
MELIS, MR ;
FADDA, F ;
SERRA, G ;
GESSA, GL .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (01) :75-79
[2]  
Barrientos A, 1998, J NEUROSCI RES, V53, P475, DOI 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0.CO
[3]  
2-3
[4]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[5]   Oxidative stress-resistant cells are protected against haloperidol toxicity [J].
Behl, C ;
Lezoualch, F ;
Widmann, M ;
Rupprecht, R ;
Holsboer, F .
BRAIN RESEARCH, 1996, 717 (1-2) :193-195
[6]  
Behl C, 1995, NEUROREPORT, V7, P360, DOI 10.1097/00001756-199512000-00085
[7]   CHANGES IN DOPA DECARBOXYLASE MESSENGER-RNA BUT NOT TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN FOLLOWING ANTIPSYCHOTIC TREATMENT [J].
BUCKLAND, PR ;
ODONOVAN, MC ;
MCGUFFIN, P .
PSYCHOPHARMACOLOGY, 1992, 108 (1-2) :98-102
[8]   An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration [J].
Cassarino, DS ;
Bennett, JP .
BRAIN RESEARCH REVIEWS, 1999, 29 (01) :1-25
[9]   TYROSINE-HYDROXYLASE AND CHOLECYSTOKININ MESSENGER-RNA LEVELS IN THE SUBSTANTIA NIGRA, VENTRAL TEGMENTAL AREA, AND LOCUS CERULEUS ARE UNAFFECTED BY ACUTE AND CHRONIC HALOPERIDOL ADMINISTRATION [J].
COTTINGHAM, SL ;
PICKAR, D ;
SHIMOTAKE, TK ;
MONTPIED, P ;
PAUL, SM ;
CRAWLEY, JN .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1990, 10 (01) :41-50
[10]   Haloperidol induced extrapyramidal reaction: lack of protective effect by vitamin E [J].
Eranti, VS ;
Gangadhar, BN ;
Janakiramaiah, N .
PSYCHOPHARMACOLOGY, 1998, 140 (04) :418-420